Skip to Content
CancersCancers
  • Systematic Review
  • Open Access

17 January 2025

12 Pages

Evaluating Offspring After Pregnancy-Associated Cancer: A Systematic Review of Neonatal Outcomes

,
,
,
,
and
1
Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd., 050474 Bucharest, Romania
2
Department of Obstetrics and Gynecology, Elias University Emergency Hospital, 17 Mărăști Blvd., 050474 Bucharest, Romania
3
Department of Neonatology, Clinical Hospital of Obstetrics and Gynecology “Prof. Dr. Panait Sârbu”, 3-5 Giulesti St., 060251 Bucharest, Romania
4
Surgical Oncology, Department of Surgery, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania

Simple Summary

Pregnancy-associated cancer (PAC) refers to cancers diagnosed during pregnancy or within a year postpartum. Although rare, the rising trend of delayed childbearing has increased its prevalence. Managing PAC is complex due to the need to balance maternal cancer treatment with fetal well-being. This systematic review examines neonatal outcomes associated with PAC, focusing on risks such as preterm birth and low birthweight. The findings highlight the critical need for multidisciplinary care to optimize outcomes for mothers and their newborns.

Abstract

Background/Objectives: Pregnancy-associated cancer (PAC) presents significant challenges for maternal and neonatal health, and yet its impact on neonatal outcomes remains poorly understood. This systematic review aims to evaluate the neonatal risks associated with PAC. Methods: A systematic search of PubMed, Embase, Scopus, and other databases was conducted up to 1 November 2024, identifying observational studies and randomized controlled trials assessing neonatal outcomes in pregnancies affected by PAC. Outcomes included preterm birth, low birthweight, macrosomia, small and large for gestational age, low Apgar score, congenital anomalies, and neonatal mortality. Results: Eleven high-quality studies encompassing over 46 million births, including 9953 PAC-affected pregnancies, were reviewed. PAC significantly increased the risks of preterm birth (adjusted ORs ranging from 1.48 to 6.34) and low birthweight (adjusted ORs up to 5.5). Other adverse outcomes included low Apgar scores and neonatal mortality, primarily linked to prematurity. Cancer type and treatment timing influenced these outcomes, with gynecological and breast cancers posing higher risks. Conclusions: Neonates of mothers with PAC face increased risks of adverse outcomes, underscoring the importance of tailored, multidisciplinary management. Further prospective studies are needed to clarify the impacts of specific cancer treatments during pregnancy.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.